ELIXIRGEN THERAPEUTICS

LIVE

Serial Number

97976453

Owner

Elixirgen Therapeutics, Inc.

Attorney

Leonard D. Bowersox

First Use Date

Jul 6, 2023

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ELIXIRGEN THERAPEUTICS Trademark

Serial Number: 97976453 • Registration: 7244784

ELIXIRGEN THERAPEUTICS is a trademark filed by Elixirgen Therapeutics, Inc. on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Elixirgen Therapeutics, Inc. (38 trademarks)

855 N. Wolfe St., Suite 624
Baltimore, MD 21205

Entity Type: 03

Legal Representation

Attorney of Record

Leonard D. Bowersox

272 trademarks filed View all →

Trademark Details

Filing Date

December 1, 2021

Registration Date

December 12, 2023

First Use Anywhere

July 6, 2023

First Use in Commerce

July 6, 2023

Published for Opposition

February 28, 2023

Goods & Services

Pharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases

Research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 12, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Dec 12, 2023 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Nov 7, 2023 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Nov 6, 2023 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 13, 2023 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Sep 12, 2023 SUPC

SOU EXTENSION 1 GRANTED

Sep 12, 2023 EX1G

DIVISIONAL PROCESSING COMPLETE

Sep 12, 2023 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 28, 2023 AITU

USE AMENDMENT FILED

Aug 22, 2023 IUAF

SOU EXTENSION 1 FILED

Aug 22, 2023 EXT1

DIVISIONAL REQUEST RECEIVED

Aug 22, 2023 DRRR

SOU TEAS EXTENSION RECEIVED

Aug 22, 2023 EEXT

TEAS STATEMENT OF USE RECEIVED

Aug 22, 2023 EISU

TEAS REQUEST TO DIVIDE RECEIVED

Aug 22, 2023 ERTD

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 25, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 28, 2023 NPUB

PUBLISHED FOR OPPOSITION

Feb 28, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 8, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 20, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 19, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 19, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 19, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 19, 2022 GNRN

NON-FINAL ACTION E-MAILED

Sep 19, 2022 GNRT

NON-FINAL ACTION WRITTEN

Sep 19, 2022 CNRT

ASSIGNED TO EXAMINER

Sep 10, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 6, 2021 NWOS

NEW APPLICATION ENTERED

Dec 4, 2021 NWAP

Related Trademarks

More from this Owner

More in Same Class

THE CLEANING EFX

FIRST AID BEAUTY FAB

FAB FIRST AID BEAUTY

NUTRIWHITE

(KV) KALIVIR IMMUNOTHERAPEUTICS

IBEROGAST